KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Encompass Health (EHC) Liabilities and Shareholders Equity (2016 - 2025)

Historic Liabilities and Shareholders Equity for Encompass Health (EHC) over the last 17 years, with Q3 2025 value amounting to $6.9 billion.

  • Encompass Health's Liabilities and Shareholders Equity rose 630.65% to $6.9 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $26.8 billion, marking a year-over-year increase of 653.87%. This contributed to the annual value of $6.5 billion for FY2024, which is 708.41% up from last year.
  • According to the latest figures from Q3 2025, Encompass Health's Liabilities and Shareholders Equity is $6.9 billion, which was up 630.65% from $6.8 billion recorded in Q2 2025.
  • Encompass Health's 5-year Liabilities and Shareholders Equity high stood at $7.1 billion for Q2 2022, and its period low was $5.5 billion during Q3 2022.
  • In the last 5 years, Encompass Health's Liabilities and Shareholders Equity had a median value of $6.5 billion in 2024 and averaged $6.4 billion.
  • Its Liabilities and Shareholders Equity has fluctuated over the past 5 years, first plummeted by 1853.4% in 2022, then skyrocketed by 900.54% in 2024.
  • Encompass Health's Liabilities and Shareholders Equity (Quarter) stood at $6.9 billion in 2021, then fell by 17.89% to $5.6 billion in 2022, then rose by 8.27% to $6.1 billion in 2023, then grew by 7.08% to $6.5 billion in 2024, then grew by 5.07% to $6.9 billion in 2025.
  • Its Liabilities and Shareholders Equity stands at $6.9 billion for Q3 2025, versus $6.8 billion for Q2 2025 and $6.6 billion for Q1 2025.